| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:87892505:1358 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:87892505:1358?format=raw |
LEADER: 01358mam a2200337 a 4500
001 4067888
005 20221027030633.0
008 020108s2002 enka b 001 0 eng
015 $aGBA2-Z5358
020 $a0124375510
035 $a(OCoLC)49664744
035 $a(OCoLC)ocm49664744
035 $9AUL7676HS
035 $a(NNC)4067888
035 $a4067888
040 $aUKM$cUKM$dNNC-M
082 04 $a616.9940426$221
245 00 $aGene therapy of cancer :$btranslational approaches from preclinical studies to clinical implementation /$cedited by Edmund C. Lattime ,Stanton L. Gerson.
250 $a2nd ed.
260 $aLondon :$bAcademic Press,$c2002.
300 $axix, 534 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
500 $aPrevious ed.: 1998.
650 0 $aCancer$xGene therapy.$0http://id.loc.gov/authorities/subjects/sh92005201
650 12 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 12 $aGenetic Therapy$xmethods.$0https://id.nlm.nih.gov/mesh/D015316Q000379
700 1 $aLattime, Edmund C.,$d1951-$0http://id.loc.gov/authorities/names/n87135814
700 1 $aGerson, Stanton L.$0http://id.loc.gov/authorities/names/nb98069820
852 00 $boff,hsl$hRC271.G45$iG463 2002 Q